50
Participants
Start Date
September 1, 2023
Primary Completion Date
December 31, 2026
Study Completion Date
December 31, 2026
Placebo
Oral placebo
H1 blockade: Telfast: 180mg Fexofenadine
H1 blockade: oral blockade with 180mg Fexofenadine
Resistance training
Resistance training: lower body exercise
RECRUITING
Department of movement and sports sciences, Ghent University, Belgium, Ghent
Research Foundation Flanders
OTHER
University Ghent
OTHER